Literature DB >> 11314716

Multichannel cochlear implantation in visually impaired patients.

H K El-Kashlan1, A Boerst, S A Telian.   

Abstract

OBJECTIVE: To evaluate the outcome of cochlear implantation in patients with severe to profound hearing loss and visual impairment. STUDY
DESIGN: Retrospective case review.
SETTING: Tertiary referral center with a large cochlear implant program. PATIENTS: Six adults and two children with severe or profound hearing loss and significant visual impairment underwent multichannel cochlear implantation. Follow-up period ranged from 6 months to 9 years. Case history, etiology of visual and hearing loss, and benefit from cochlear implant were evaluated.
INTERVENTIONS: Cochlear implantation and subsequent rehabilitation. MAIN OUTCOME MEASURES: Speech perception measures were selected based on the patient age and cognitive abilities. Identical measures were used in each patient before and after implantation.
RESULTS: As a group, patients did well after cochlear implantation. There was significant improvement in speech perception when compared with the score before implantation.
CONCLUSIONS: Cochlear implants can play a significant rehabilitative role in patients with severe visual and auditory impairment. Additional skills are required by the implant team for rehabilitation of patients with multiple sensory deficits.

Entities:  

Mesh:

Year:  2001        PMID: 11314716     DOI: 10.1097/00129492-200101000-00010

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  2 in total

1.  Cochlear implantations in visually impaired patients.

Authors:  Kenji Takasaki; Yokihiko Kanda; Hidetaka Kumagami; Haruo Yashida; Tomomi Yamamoto-Fukuda; Ikue Miyamoto; Haruo Takahashi
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-11-03       Impact factor: 2.503

2.  Auditory and language skills development after cochlear implantation in children with multiple disabilities.

Authors:  Tamer A Mesallam; Medhat Yousef; Ayna Almasaad
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-10-27       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.